Intrinsic Value

Kiniksa Pharmaceuticals, Ltd. (KNSA)

$18.498

+0.62 (+3.46%)

Enterprise Value -
Net Debt -95.70
Equity Value -
Shares Outstanding 71.92
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt